Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(2)

Detailed Status

Completed3

unknown2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed350%

unknown233%

terminated117%

Recent Activity

0 active trials

Showing 5 of 6

unknownnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT02688478Not Applicable

The Phthalate-Allergen Immune Response Study

Unknown

NCT02017431Not Applicable

Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction

Completed

NCT01792232Not Applicable

Effects of Co-Exposure to Air Pollution and Allergen

Completed

NCT01759849

Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma

Completed

NCT01723397Not Applicable

Effect of Nasaleze on Nasal Challenge With Allergen

Terminated

NCT01110837Not Applicable

Repeat Dose Nasal Allergen Challenge

Unknown

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6